These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Proteomics in hematologic malignancies. Caron M; Joubert-Caron R Expert Rev Proteomics; 2005 Aug; 2(4):567-76. PubMed ID: 16097889 [TBL] [Abstract][Full Text] [Related]
9. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
10. Emerging targets for hematological malignancies. Cilloni D; Frassoni F; Saglio G Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146 [TBL] [Abstract][Full Text] [Related]
11. Recent advancements of flow cytometry: new applications in hematology and oncology. Woo J; Baumann A; Arguello V Expert Rev Mol Diagn; 2014 Jan; 14(1):67-81. PubMed ID: 24308362 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous presentation of hematological malignancies. Eberle FC; Metzler G; Weisel KC; Berneburg M; Yazdi AS Eur J Dermatol; 2013; 23(3):372-7. PubMed ID: 23782893 [TBL] [Abstract][Full Text] [Related]
13. Intracellular Phospho-Flow cytometry reveals novel insights into TCR proximal signaling events. A comparison with Western blot. Haas A; Weckbecker G; Welzenbach K Cytometry A; 2008 Sep; 73(9):799-807. PubMed ID: 18548611 [TBL] [Abstract][Full Text] [Related]
14. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies. Martínez A; Aymerich M; Castillo M; Colomer D; Bellosillo B; Campo E; Villamor N Cytometry B Clin Cytom; 2003 Nov; 56(1):8-15. PubMed ID: 14582132 [TBL] [Abstract][Full Text] [Related]
16. Single cell phospho-specific flow cytometry can detect dynamic changes of phospho-Stat1 level in lung cancer cells. Lin CC; Huang WL; Su WP; Chen HH; Lai WW; Yan JJ; Su WC Cytometry A; 2010 Nov; 77(11):1008-19. PubMed ID: 20814891 [TBL] [Abstract][Full Text] [Related]
17. [Genetic analysis and immunophenotyping in the diagnosis of hematological disease]. Hergersberg M; Röthlisberger B; Heijnen IA; Huber AR Ther Umsch; 2004 Feb; 61(2):83-91. PubMed ID: 15018391 [TBL] [Abstract][Full Text] [Related]
18. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies]. Drénou B; Fardel O; Fauchet R; Amiot L Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230 [TBL] [Abstract][Full Text] [Related]
19. [Noncanonical NF-κB pathway and hematological malignancies]. Wang WJ; Sun AN; Guo F Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1069-73. PubMed ID: 20723331 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies. Dzikiewicz-Krawczyk A Crit Rev Oncol Hematol; 2015 Jan; 93(1):1-17. PubMed ID: 25217091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]